HIV Wasting Syndrome: Clinical Trials

14 trials for HIV Wasting Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed. 5 Phase 2, 3 Not applicable, 2 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Not applicable3Completed 3
Phase 12Completed 2
Phase 31Completed 1
Phase 41Completed 1

Follow HIV Wasting Syndrome: new trials by email Literature Review of HIV Wasting Syndrome trials Research Report on HIV Wasting Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL, Megestrol acetate oral suspension 40 mg/mL - HIV Infections, Cachexia
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company632004-12-012017-10-05
Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients
Abacavir sulfate, Atazanavir/Ritonavir, Lopinavir/Ritonavir - HIV Infections, Lipodystrophy
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)1502002-03-012013-07-29
The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children
HIV Infections, HIV Wasting Syndrome
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1002000-06-012014-10-29
A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss
Optimune oral nutritional supplement - HIV Infections, HIV Wasting Syndrome
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)561999-05-012013-07-29
AIDS Wasting in Women: Anabolic Effects of Testosterone
Testosterone - AIDS Wasting Syndrome
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1998-09-012010-02-15
Nutrition Intervention in AIDS Wasting
oxandrolone, Progressive Resistance Training - HIV Wasting Syndrome
Phase 4CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1998-01-012010-01-13
Growth Hormone in the Treatment of HIV-Associated Wasting
Somatropin; Recombinant human growth hormone (r hGH) - HIV Infections, HIV Wasting Syndrome
Phase 3CompletedEMD Serono1997-07-012013-10-22
A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements
Multivitamin and mineral supplements, Peptamen, NuBasics - HIV Infections, HIV Wasting Syndrome
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)5361996-06-012013-10-01
Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting
megestrol, Exercise - Acquired Immunodeficiency Syndrome, HIV Wasting Syndrome
Not applicableCompletedNational Center for Research Resources (NCRR)691995-06-012005-06-24
A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
Nandrolone decanoate - HIV Infections, HIV Wasting Syndrome
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)382021-10-29
A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome
Dronabinol, Megestrol acetate - Cachexia, HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)562008-08-25
A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss
Testosterone enanthate, Megestrol acetate - HIV Infections, HIV Wasting Syndrome
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)802021-11-01
A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting Syndrome
Thalidomide - HIV Infections, HIV Wasting Syndrome
Phase 2CompletedCelgene Corporation752005-06-24
Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome
Thalidomide - HIV Infections, HIV Wasting Syndrome
Not applicableCompletedCelgene Corporation2005-06-24

Narrower conditions

HIV Infections (12)  ·  Acquired Immunodeficiency Syndrome (7)  ·  Cachexia (4)  ·  Weight Loss (4)  ·  AIDS-Related Complex (2)  ·  Lipodystrophy (2)  ·  Wasting Syndrome (2)  ·  Anorexia (1)  ·  Body Weight Changes (1)  ·  Communicable Diseases (1)  ·  Emaciation (1)  ·  Feeding and Eating Disorders (1)  ·  Immune System Diseases (1)  ·  Motor Activity (1)

Broader conditions

Blood-Borne Infections (14)  ·  Genital Diseases (14)  ·  Immunologic Deficiency Syndromes (14)  ·  Infections (14)  ·  Lentivirus Infections (14)  ·  Metabolic Diseases (14)  ·  Nutrition Disorders (14)  ·  Nutritional and Metabolic Diseases (14)  ·  RNA Virus Infections (14)  ·  Retroviridae Infections (14)  ·  Sexually Transmitted Diseases (14)  ·  Sexually Transmitted Diseases, Viral (14)  ·  Urogenital Diseases (14)  ·  Communicable Diseases (13)  ·  Immune System Diseases (13)

Interventions

Megestrol Acetate (3)  ·  Thalidomide (2)  ·  Dronabinol (1)  ·  Exercise (1)  ·  Geritol (1)  ·  Growth Hormone (1)  ·  Human Growth Hormone (1)  ·  Lopinavir (1)  ·  Megestrol (1)  ·  Nandrolone Decanoate (1)  ·  Nevirapine (1)  ·  Oxandrolone (1)  ·  Peptamen (1)  ·  Testosterone (1)  ·  abacavir (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (7)  ·  Celgene Corporation (2)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2)  ·  EMD Serono (1)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)  ·  National Center for Research Resources (NCRR) (1)

Countries

United States (12)  ·  Puerto Rico (3)  ·  India (1)  ·  South Africa (1)

Top investigators

Abby Shevitz, MD (1)  ·  Bruce R. Bistrian, MD (1)  ·  Caroline Chantry (1)  ·  Egorin M (1)  ·  Elizabeth Svanbert, MD, PhD (1)  ·  Fred R. Sattler, MD (1)  ·  Galetto G (1)  ·  Gilbert CL (1)  ·  J Currier (1)  ·  Jamie Hayden Von Roenn (1)  ·  Jan Fourie, MD (1)  ·  Joseph Cervia (1)  ·  K Mulligan (1)  ·  Kathleen Mulligan, MD (1)  ·  Mulligan K (1)

Results publications

PMID 18519448, PMID 18614924, PMID 19299471, PMID 20345880, PMID 20631646